These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7455757)

  • 1. NIH Consensus Development Panel summary, Cervical cancer screening: the Pap smear.
    South Med J; 1981 Jan; 74(1):87-8. PubMed ID: 7455757
    [No Abstract]   [Full Text] [Related]  

  • 2. NIH Consensus Development Conference summary. Cervical cancer screening: the Pap smear.
    J Tenn Med Assoc; 1981 May; 74(5):339-42. PubMed ID: 7242079
    [No Abstract]   [Full Text] [Related]  

  • 3. Results from a cervical cancer screening programme in Manitoba, Canada.
    Choi NW; Nelson NA
    IARC Sci Publ; 1986; (76):61-7. PubMed ID: 3570416
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening: the Pap smear. Sponsored by the National Cancer Institute. Assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1981 Jan; 45(1):33-6. PubMed ID: 7226788
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for squamous cervical cancer--the duration of low risk following negative results in cervical cytology test: introduction. IARC Working Group on Cervical Cancer Screening.
    IARC Sci Publ; 1986; (76):15-24. PubMed ID: 3570401
    [No Abstract]   [Full Text] [Related]  

  • 8. Cervical cancer screening in north-east Scotland.
    Macgregor JE; Moss S; Parkin DM; Day NE
    IARC Sci Publ; 1986; (76):25-36. PubMed ID: 3570409
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytological mass screening in Ostfold County, Norway.
    Magnus K; Langmark F
    IARC Sci Publ; 1986; (76):87-90. PubMed ID: 3570418
    [No Abstract]   [Full Text] [Related]  

  • 10. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Colpocytologic study in Siena and the province in the decade from 1973 to 1982].
    Cintorino M; Citerni MR; del Vecchio MT; Lapucci T; La Rosa R; Ricci MG; Sforza V
    Minerva Ginecol; 1985 Apr; 37(4):173-8. PubMed ID: 4034062
    [No Abstract]   [Full Text] [Related]  

  • 12. Mass cervical cancer screening program by irrigation smear in Japan.
    Kawashima Y; Ino S; Tashiro K; Tachibana M; Masukawa T
    Obstet Gynecol; 1968 Jul; 32(1):17-23. PubMed ID: 5742086
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the appropriate frequency of the cervical cancer screening (author's transl)].
    Hando T; Kodama S; Obata N; Goto A; Takeuchi S; Aoki S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1205-8. PubMed ID: 7276648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 16. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Practical points of reference for the prevention and early detection of cervical cancer].
    Ebeling K
    Z Arztl Fortbild (Jena); 1986; 80(7):306-10. PubMed ID: 3727623
    [No Abstract]   [Full Text] [Related]  

  • 19. Pap smear screening intervals among patients with cervical cancer in West Virginia.
    Jubelirer S; Baron R; Mairs D
    Prog Clin Biol Res; 1989; 293():323-30. PubMed ID: 2726944
    [No Abstract]   [Full Text] [Related]  

  • 20. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.